Keratoconus Institute of Maryland in conjunction with OMNI Eye Specialists now offering FDA Approved Corneal Cross-Linking (CXL) for the treatment of Keratoconus.
Epi-off cross-linking performed with Photrexa® Drug Formulations, Photrexa® Viscous, Photrexa® and KXL® System is the only cross-linking procedure approved by the FDA.
What Is the Difference Between FDA-Approved & Non-FDA-Approved Cross-Linking?